Tasly Pharmaceutical Group Co Ltd (600535) - Financial and Strategic SWOT Analysis Review

Tasly Pharmaceutical Group Co Ltd (600535) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Tasly Pharmaceutical Group Co Ltd (Tasly) manufactures and distributes chemical medicine, biological medicine, healthcare products, traditional Chinese medicine (TCM), functional food and other products. The companys product line includes herbal medicine, chemical medicine, health product, pharmaceutical substances and active pharmaceutical ingredients (APIs), herbal extract, tea, cosmetics, daily hygiene product series and medical equipment. It markets products in domestic market through its own sales force and through distributors and subsidiaries in Malaysia, Indonesia, Vietnam, South Korea, Pakistan, Thailand, Istanbul, Botswana, South Africa, Ghana, Kenya, Zambia, Nigeria, Russia, Netherlands, Bahamas and the US. Tasly is headquartered in Tianjin, China.

Tasly Pharmaceutical Group Co Ltd Key Recent Developments

Mar 28,2019: Tasly Pharmaceutical Group taps Shuwen Biotech for companion diagnostic services

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company




Section 1 - About the Company
Tasly Pharmaceutical Group Co Ltd - Key Facts
Tasly Pharmaceutical Group Co Ltd - Key Employees
Tasly Pharmaceutical Group Co Ltd - Major Products and Services
Tasly Pharmaceutical Group Co Ltd - History
Tasly Pharmaceutical Group Co Ltd - Company Statement
Tasly Pharmaceutical Group Co Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 Company Analysis
Company Overview
Tasly Pharmaceutical Group Co Ltd - Business Description
Tasly Pharmaceutical Group Co Ltd - Corporate Strategy
Tasly Pharmaceutical Group Co Ltd - SWOT Analysis
SWOT Analysis - Overview
Tasly Pharmaceutical Group Co Ltd - Strengths
Tasly Pharmaceutical Group Co Ltd - Weaknesses
Tasly Pharmaceutical Group Co Ltd - Opportunities
Tasly Pharmaceutical Group Co Ltd - Threats
Tasly Pharmaceutical Group Co Ltd - Key Competitors
Section 3 Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 Companys Lifesciences Financial Deals and Alliances
Tasly Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Tasly Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Tasly Pharmaceutical Group Co Ltd, Recent Deals Summary
Section 5 Companys Recent Developments
Mar 28, 2019: Tasly Pharmaceutical Group taps Shuwen Biotech for companion diagnostic services
Section 6 Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables


Tasly Pharmaceutical Group Co Ltd, Key Facts
Tasly Pharmaceutical Group Co Ltd, Key Employees
Tasly Pharmaceutical Group Co Ltd, Major Products and Services
Tasly Pharmaceutical Group Co Ltd, History
Tasly Pharmaceutical Group Co Ltd, Subsidiaries
Tasly Pharmaceutical Group Co Ltd, Joint Venture
Tasly Pharmaceutical Group Co Ltd, Key Competitors
Tasly Pharmaceutical Group Co Ltd, Ratios based on current share price
Tasly Pharmaceutical Group Co Ltd, Annual Ratios
Tasly Pharmaceutical Group Co Ltd, Annual Ratios (Cont...1)
Tasly Pharmaceutical Group Co Ltd, Annual Ratios (Cont...2)
Tasly Pharmaceutical Group Co Ltd, Interim Ratios
Tasly Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Tasly Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Tasly Pharmaceutical Group Co Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures


Tasly Pharmaceutical Group Co Ltd, Performance Chart (2015 - 2019)
Tasly Pharmaceutical Group Co Ltd, Ratio Charts
Tasly Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Tasly Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

Tasly Pharmaceutical Group Co Ltd (600535) - Financial and Strategic SWOT Analysis Review

Tasly Pharmaceutical Group Co Ltd (600535) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been

USD 125 View Report

Tasly Pharmaceutical Group Co, Ltd Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

Tasly Pharmaceutical Group Co, Ltd Company Profile is a detailed strategic and analytical report on Tasly Pharmaceutical Group Co, Ltd. The 2018 version of the report offers detailed insights into

USD 200 View Report

Livzon Pharmaceutical Group Co Ltd (000513) - Financial and Strategic SWOT Analysis Review

Livzon Pharmaceutical Group Co Ltd (Livzon) a subsidiary of Joincare Pharmaceutical Group Industry Co Ltd, is a pharmaceutical company which is engaged in developing, manufacturing and distributing pharmaceutical products. The

USD 300 View Report

Jiangsu Jumpcan Pharmaceutical Group Co Ltd (600566) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Jiangsu Jumpcan Pharmaceutical Group Co Ltd (Jiangsu Jumpcan Pharma) is a developer, manufacturer and distributor of Chinese traditional medicine, Western medicine, daily use chemicals and healthcare products. The company offers

USD 250 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available